Oxandrolone Tablets, USP, 10 mg, Rx Only, C-III, 60-count bottle, Manufactured for: Upsher-Smith Labs, Minneapolis, MN 55447, by: Pharmaceutics International, Inc., Hunt Valley, MD 21031, NDC 0245-0272-06
Published April 30, 2014 · Recall initiated: April 14, 2014
Summary
FDA records drug Class III recall D-1255-2014, published April 30, 2014 and initiated April 14, 2014. Recalling firm: Upsher Smith Laboratories, Inc.; Status: Terminated; Reported quantity: 1,185 bottles; Lot: Lot #2802.042A, Exp. 10/2015. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Missing Label; Three cases of product (total of 36 bottles) were packaged without the primary label on the bottle. The cases were, however, packaged in the correct finished product shipper, labeled with the correct shipper bar code label, sealed with tamper-evident tape and erroneously shipped to Upsher-Smith.
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Upsher Smith Laboratories, Inc.
- Distributor
- Nationwide
- Lot
- Lot #2802.042A, Exp. 10/2015
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADay Time Cold & Flu, Multi-Symptom, Non-Drowsy, Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, 4, 6,April 30, 2014
- FDANon-Drowsy 24 Hour Formula Allergy Relief and Nasal Decongestant, Pseudoephedrine Sulfate, USP 240 mg ,April 30, 2014
- FDATikosyn® (dofetilide) 500 mcg (0.5mg) capsules, 60-count bottle, Rx only Pfizer Labs, Division of Pfizer Inc.April 30, 2014
- FDAPotassium Chloride for Inj. Concentrate, USP, 40 mEq (2 mEq/mL), 20 mL Single-dose Fliptop Vial, For IV use,April 30, 2014
- FDAPropranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured forFebruary 20, 2013
- FDADivalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle,January 23, 2013
Questions about this recall
Was Oxandrolone Tablets, USP, 10 mg, Rx Only, C-III, 60-count bottle, Manufactured for: Upsher-Smith Labs, Minneapolis, MN 55447, by: Pharmaceutics International, Inc., Hunt Valley, MD 21031, NDC 0245-0272-06 recalled?
Yes. FDA published recall D-1255-2014 on April 30, 2014. Reported hazard: Labeling: Missing Label; Three cases of product (total of 36 bottles) were packaged without the primary label on the bottle. The cases were, however, packaged in the correct finished product shipper, labeled with the correct shipper bar code label, sealed with tamper-evident tape and erroneously shipped to Upsher-Smith.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone